Table 3.
Variable | Univariate Cox analysis HR (95% CI) | P value | Multivariate Cox analysis HR (95% CI) | P value |
---|---|---|---|---|
Age (yr) | ||||
<60 | 1.3 (0.74–2.6) | .682 | – | – |
≥60 | ||||
Gender | ||||
Male | 1.4 (0.87–2.48) | .213 | – | – |
Female | ||||
Smoking history | ||||
Yes | 0.97 (0.59–1.68) | .758 | – | – |
No | ||||
Organization type | ||||
Squamous cell carcinoma | 1.1 (0.72–1.83) | .327 | – | – |
Adenocarcinoma | ||||
Clinical staging | ||||
I/II | 2.2 (1.2–2.91) | .009 | 0.96 (0.53–2.7) | .869 |
III/IV | ||||
Lymph node metastasis | ||||
No | 4.5 (2.4–8.5) | <.001 | 4.0 (2.1–7.7) | <.001 |
Yes | ||||
Distant metastasis | ||||
No | 2.2 (1.0–4.6) | .0435 | 1.3 (0.61–2.5) | .792 |
Yes | ||||
Differentiation | ||||
Highly and moderately differentiated | 2.5 (1.5–4.8) | .0472 | 1.6 (0.87–2.7) | .316 |
Poorly differentiated | ||||
Tumor size | ||||
≥3 cm | 1.7 (0.87–2.39) | .219 | – | – |
<3 cm | ||||
Expression of miR–92a | ||||
High expression | 2.4 (1.2–4.3) | .003 | 1.8 (1.0–3.2) | .036 |
Low expression |
NSCLC = non-small cell lung cancer.